Skip to main content
Premium Trial:

Request an Annual Quote

OncoCyte: Melinda Griffith

OncoCyte has appointed Melinda Griffith to its board of directors. Griffith is a senior executive who has led business development, licensing, and legal activities for a number of diagnostic, device and pharmaceutical companies. In addition to her board appointment for OncoCyte, she currently serves as vice president of strategic alliances and chief legal counsel for the Parker Institute for Cancer Immunotherapy an dis chair of the board of directors for intenrational health non-profit Thrive Networks.

Prior to this, Griffith held a number of executive roles at public and private biotech companies, including GE Healthcare's Clarient Cancer Laboratories, Genelabs Technologies, CardioDx, Tethys BioSciences, and Axys Pharmaceuticals, Cetus Corporation, and Hoffmann La-Roche.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.